Microproteinuria in patients with inflammatory bowel disease: Is it associated with the disease activity or the treatment with 5-aminosalicylic acid?

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 5

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

353

HTML

2315

Figures (1-2)

133

Tables (1-5)

124

Sum=2925

Feb 7, 2006 (publication date) through Apr 25, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Clinical Research

World J Gastroenterol. Feb 7, 2006; 12(5): 739-746
Published online Feb 7, 2006. doi: 10.3748/wjg.v12.i5.739

Figure 1 Correlation of IBD patients’ microproteinuria (mALB, β₂mGLB, β-NAG) with 5-ASA treatment.

Figure 2 Changes of microproteinuria in the first-diagnosed patients with active IBD (n = 22) before and after inducing remission.

Citation: Poulou AC, Goumas KE, Dandakis DC, Tyrmpas I, Panagiotaki M, Georgouli A, Soutos DC, Archimandritis A. Microproteinuria in patients with inflammatory bowel disease: Is it associated with the disease activity or the treatment with 5-aminosalicylic acid? World J Gastroenterol 2006; 12(5): 739-746
URL: https://www.wjgnet.com/1007-9327/full/v12/i5/739.htm
DOI: https://dx.doi.org/10.3748/wjg.v12.i5.739